ArticleScientifica2026
Herbal Formula IM-B Possesses Antioxidant Activities and Reduces Expression of Proinflammatory Cytokines in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages.
Article in Scientifica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IM-B is a herbal formula comprising extracts derived from four medicinal herbs previously reported to exhibit antioxidant and anti-inflammatory properties. In this study, the bioactive compounds of IM-B extract, as well as its antioxidant and anti-inflammatory properties, were explored. Chemical compounds in IM-B extract were identified through phytochemical analysis using LC-ESI-QTOF-MS/MS. Fifteen compounds comprising naringenin 5-methyl ether, alpinetin, pinocembrin, 2',4',6'-trihydroxydihydrochalcone, demethoxycurcumin, curcumin, alpinetin methyl ether, caffeic acid, myrcene, bisdemethoxycurcumin, geraniol, pinostrobin, pinostrobin chalcone, cannabidiol, and astaxanthin were analyzed. Based on the total phenolic (106.20 ± 3.11 mg GAE/g extract) and flavonoid (94.65 ± 2.65 mg QE/g extract) contents of the IM-B extract, we consider it a good source of these secondary metabolites. Its antioxidant activities were 4.03 ± 0.63 μg/mL, 9.11 ± 0.57 μg/mL, and 126.84 ± 0.30 mg FeSO
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.